On behalf of the Local Organising Committee I have great
pleasure in inviting international researchers and their
companions to Melbourne, Australia in June/July, 2010 for
the 11th International Symposium on the Genetics of Industrial
Microorganisms, GIM2010.
GIM is an extra special meeting that occurs once every
four years and this will be the first time GIM has been
held in Australia. Therefore we are eager to offer our colleagues
hospitality and exhibit the beauty of our natural resources.
Melbourne is regarded as one of the top conference destinations
in the world and we hope that you will come to agree.
CALL FOR ABSTRACTS EXTENDED UNTIL 12 FEBRUARY 2010!
The deadline for abstract submissions has been extended to Friday 12 February. Do not miss out on this opportunity to participate in GIM 2010.
Submit your abstract now
STUDENT FUNDING APPLICATIONS EXTENDED UNTIL 12 FEBRUARY 2010
If you are an international or national student, do not miss this opportunity to receive a complimentary registration to attend GIM 2010. Students will be accepted based on specific criteria.
Click here to apply
This This month’s featured speaker is
Dr Alex Franzusoff. Dr Franzusoff will be a symposia speaker at GIM 2010.
Dr Alex Franzusoff
Dr Franzusoff has carried out cutting edge research in immunotherapy against cancer and infectious disease, as well as HIV virus assembly, secretory pathway function and engineering of recombinant yeast for the production of foreign proteins. In addition to co-inventing the Tarmogen technology, Dr. Franzusoff has authored more than 40 publications on immunotherapy against infectious diseases and cancer, yeast cell biology, HIV infectivity and recombinant DNA engineering.
Dr Franzusoff has carried out cutting edge research in immunotherapy against cancer and infectious disease, as well as HIV virus assembly, secretory pathway function and engineering of recombinant yeast for the production of foreign proteins. In addition to co-inventing the Tarmogen technology, Dr. Franzusoff has authored more than 40 publications on immunotherapy against infectious diseases and cancer, yeast cell biology, HIV infectivity and recombinant DNA engineering.
